MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) (EKNMERC-GCF-SL)
Expression of Mitochondria-Endoplasmic Reticulum Contact Proteins in Saliva and Gingival Crevicular Fluid in Patients With Periodontal Disease: ELISA and Calcium Analysis
This observational cross-sectional study investigates the levels of mitochondria-endoplasmic reticulum contact site (MERC) proteins in saliva and gingival crevicular fluid (GCF) of individuals with different periodontal conditions. MERCs are specialized regions where mitochondria and the endoplasmic reticulum physically connect, and they play important roles in calcium signaling, oxidative stress regulation, and cell death (apoptosis). Disruption of these contact sites has been linked to inflammatory diseases, including periodontal disease.
The study includes 48 systemically healthy, non-smoking adults divided into three groups: periodontally healthy (n=16), gingivitis (n=16), and Stage III Grade B periodontitis (n=16). Five MERC-associated proteins (VAPB, PTPIP51, IP3R, GRP75, and VDAC) are measured in GCF and saliva samples using ELISA. Additionally, caspase-3 (a marker of apoptosis), reactive oxygen species (a marker of oxidative stress), and calcium levels are measured to explore relationships between MERC proteins and key cellular processes involved in periodontal tissue destruction.
The purpose of this study is to determine whether MERC protein levels differ across periodontal conditions and to evaluate their associations with clinical periodontal parameters, oxidative stress, calcium metabolism, and apoptosis.
研究概览
详细说明
Mitochondria-endoplasmic reticulum contact sites (MERCs) are specialized structural domains that physically link mitochondria and the endoplasmic reticulum. These contact sites are enriched with functional proteins that coordinate calcium transfer between the two organelles, regulate lipid metabolism, modulate oxidative stress responses, and control apoptotic signaling pathways. Key MERC-associated proteins include VAPB (vesicle-associated membrane protein-associated protein B), PTPIP51 (protein tyrosine phosphatase-interacting protein 51), IP3R (inositol 1,4,5-trisphosphate receptor), GRP75 (glucose-regulated protein 75), and VDAC (voltage-dependent anion channel). The IP3R-GRP75-VDAC complex facilitates calcium transfer from the ER to mitochondria, while the VAPB-PTPIP51 complex modulates this process and influences ATP production and autophagy. Disruption of MERC homeostasis has been implicated in neurodegenerative diseases, metabolic disorders, and periodontal disease. Periodontal disease is a chronic inflammatory condition driven by microbial dental plaque, leading to destruction of periodontal tissues and alveolar bone. Previous studies demonstrated dysregulation of MERC-related gene expression (MFN1, IP3R, GRP75, PINK1, SIGMAR1) in human gingival fibroblasts exposed to Porphyromonas gingivalis and Fusobacterium nucleatum.
The present study measures the concentrations and total amounts of five MERC proteins-VAPB, PTPIP51, IP3R, GRP75, and VDAC-together with caspase-3 (an apoptosis marker), reactive oxygen species (ROS, an oxidative stress marker), and calcium levels in gingival crevicular fluid (GCF) and unstimulated whole saliva obtained from systemically healthy, non-smoking participants. Participants are classified into three groups according to the 2017 World Workshop classification: periodontally healthy (n=16), gingivitis (n=16), and Stage III Grade B periodontitis (n=16), with equal sex distribution (8 males and 8 females per group). GCF samples are collected from three single-rooted teeth per participant using standardized paper strips (Periopaper), with absorbed volume measured using a Periotron 8000. Saliva samples are collected using the passive drooling method. Biomarker levels are quantified using commercially available ELISA kits. Clinical periodontal parameters recorded include Plaque Index (PI), Gingival Index (GI), Probing Depth (PD), Bleeding on Probing (BOP%), and Clinical Attachment Level (CAL). Correlations between biomarker levels and clinical parameters are analyzed. Receiver operating characteristic (ROC) curve analysis is performed to evaluate the diagnostic potential of the biomarkers.
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
Malatya
-
Malatya、Malatya、土耳其(türkiye)、44210
- Inönü University Faculty of Dentistry, Department of Periodontology
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
取样方法
研究人群
描述
Inclusion Criteria:
- Systemically healthy individuals aged 18-65 years
- Non-smokers or smoking cessation more than 5 years ago
- Healthy group: No history of periodontal disease, ≥20 teeth, probing depth (PD) ≤3 mm at all sites, bleeding on probing (BOP) <10%, radiographic CEJ-to-alveolar bone crest distance ≤3 mm in ≥95% of teeth
- Gingivitis group: No history of periodontal disease, ≥20 teeth, PD ≤3 mm at all sites, BOP ≥30%, radiographic CEJ-to-alveolar bone crest distance ≤3 mm in ≥95% of teeth
- Periodontitis group: ≥15 teeth, >30% of teeth affected by periodontal disease, PD ≥6 mm, clinical attachment loss (CAL) ≥5 mm, vertical bone loss ≥3 mm, Class II or III furcation involvement, radiographic alveolar bone loss extending to the middle third or beyond (≥33%), bone loss-to-age ratio between 0.25 and 1.00
Exclusion Criteria:
- Periodontal treatment or antibiotic use within the past 6 months
- Fewer than 20 teeth (excluding third molars)
- Presence of any systemic disease
- Current smoking or cessation within the past 5 years
- Use of immunosuppressive medication
- Alcohol consumption
- Regular medication use
- Pregnancy or lactation
- Need for antibiotic prophylaxis prior to dental procedures
- Prosthetic restorations on the teeth selected for sampling
学习计划
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
Periodontally Healthy
Systemically healthy, non-smoking individuals with no history of periodontal disease.
Inclusion criteria: ≥20 teeth, probing depth (PD) ≤3 mm at all sites, bleeding on probing (BOP) <10%, and radiographic CEJ-to-alveolar bone crest distance ≤3 mm in ≥95% of teeth.
n=16 (8 females, 8 males).
|
Levels of MERC-associated proteins (VAPB, PTPIP51, IP3R, GRP75, VDAC), caspase-3, reactive oxygen species, and calcium were measured in gingival crevicular fluid and unstimulated whole saliva samples using commercially available ELISA kits.
Absorbance was read at 450 nm.
No therapeutic intervention was applied; this is an observational biomarker measurement study.
Calcium levels were measured in gingival crevicular fluid and unstimulated whole saliva samples using a commercially available ELISA kit (ELK Biotechnology, China).
Concentrations were expressed as μmol/mL and total amounts as μmol/30s.
Analytical range: 0.15-40 μmol/mL.
No therapeutic intervention was applied.
|
|
Gingivitis
Systemically healthy, non-smoking individuals with gingival inflammation but no attachment loss.
Inclusion criteria: ≥20 teeth, PD ≤3 mm at all sites, BOP ≥30%, and radiographic CEJ-to-alveolar bone crest distance ≤3 mm in ≥95% of teeth.
n=16 (8 females, 8 males).
|
Levels of MERC-associated proteins (VAPB, PTPIP51, IP3R, GRP75, VDAC), caspase-3, reactive oxygen species, and calcium were measured in gingival crevicular fluid and unstimulated whole saliva samples using commercially available ELISA kits.
Absorbance was read at 450 nm.
No therapeutic intervention was applied; this is an observational biomarker measurement study.
Calcium levels were measured in gingival crevicular fluid and unstimulated whole saliva samples using a commercially available ELISA kit (ELK Biotechnology, China).
Concentrations were expressed as μmol/mL and total amounts as μmol/30s.
Analytical range: 0.15-40 μmol/mL.
No therapeutic intervention was applied.
|
|
Stage III Grade B Periodontitis
Systemically healthy, non-smoking individuals with Stage III Grade B periodontitis.
Inclusion criteria: ≥15 teeth, >30% of teeth affected, PD ≥6 mm, CAL ≥5 mm, vertical bone loss ≥3 mm, Class II/III furcation involvement, radiographic bone loss extending to the middle third or beyond (≥33%), and bone loss-to-age ratio between 0.25 and 1.00.
n=16 (8 females, 8 males).
|
Levels of MERC-associated proteins (VAPB, PTPIP51, IP3R, GRP75, VDAC), caspase-3, reactive oxygen species, and calcium were measured in gingival crevicular fluid and unstimulated whole saliva samples using commercially available ELISA kits.
Absorbance was read at 450 nm.
No therapeutic intervention was applied; this is an observational biomarker measurement study.
Calcium levels were measured in gingival crevicular fluid and unstimulated whole saliva samples using a commercially available ELISA kit (ELK Biotechnology, China).
Concentrations were expressed as μmol/mL and total amounts as μmol/30s.
Analytical range: 0.15-40 μmol/mL.
No therapeutic intervention was applied.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
GCF VAPB Levels
大体时间:At baseline (single visit)
|
Concentrations and total amounts of VAPB in gingival crevicular fluid measured by ELISA.
|
At baseline (single visit)
|
|
Salivary VAPB Levels
大体时间:At baseline (single visit)
|
Concentrations of VAPB (pg/mL) in unstimulated whole saliva measured by ELISA.
|
At baseline (single visit)
|
|
GCF PTPIP51 Levels
大体时间:At baseline (single visit)
|
Concentrations and total amounts of PTPIP51 in gingival crevicular fluid measured by ELISA.
|
At baseline (single visit)
|
|
Salivary PTPIP51 Levels
大体时间:At baseline (single visit)
|
Concentrations of PTPIP51 (ng/L) in unstimulated whole saliva measured by ELISA.
|
At baseline (single visit)
|
|
GCF IP3R Levels
大体时间:At baseline (single visit)
|
Concentrations and total amounts of IP3R in gingival crevicular fluid measured by ELISA.
|
At baseline (single visit)
|
|
Salivary IP3R Levels
大体时间:At baseline (single visit)
|
Concentrations of IP3R (ng/mL) in unstimulated whole saliva measured by ELISA.
|
At baseline (single visit)
|
|
GCF GRP75 Levels
大体时间:At baseline (single visit)
|
Concentrations and total amounts of GRP75 in gingival crevicular fluid measured by ELISA.
|
At baseline (single visit)
|
|
Salivary GRP75 Levels
大体时间:At baseline (single visit)
|
Concentrations of GRP75 (ng/mL) in unstimulated whole saliva measured by ELISA.
|
At baseline (single visit)
|
|
GCF VDAC Levels
大体时间:At baseline (single visit)
|
Concentrations and total amounts of VDAC in gingival crevicular fluid measured by ELISA.
|
At baseline (single visit)
|
|
Salivary VDAC Levels
大体时间:At baseline (single visit)
|
Concentrations of VDAC (ng/mL) in unstimulated whole saliva measured by ELISA.
|
At baseline (single visit)
|
|
GCF Caspase-3 Levels
大体时间:At baseline (single visit)
|
Concentrations and total amounts of caspase-3 (ng/mL) in gingival crevicular fluid measured by ELISA.
|
At baseline (single visit)
|
|
Salivary Caspase-3 Levels
大体时间:At baseline (single visit)
|
Concentrations of caspase-3 (ng/mL) in unstimulated whole saliva measured by ELISA.
|
At baseline (single visit)
|
|
GCF Reactive Oxygen Species Levels
大体时间:At baseline (single visit)
|
Concentrations and total amounts of reactive oxygen species (ROS) in gingival crevicular fluid measured by ELISA.
|
At baseline (single visit)
|
|
Salivary Reactive Oxygen Species Levels
大体时间:At baseline (single visit)
|
Concentrations of reactive oxygen species (ROS) in unstimulated whole saliva measured by ELISA.
|
At baseline (single visit)
|
|
GCF Calcium Levels
大体时间:At baseline (single visit)
|
Concentrations and total amounts of calcium (µmol/mL) in gingival crevicular fluid measured by ELISA.
|
At baseline (single visit)
|
|
Salivary Calcium Levels
大体时间:At baseline (single visit)
|
Concentrations of calcium (µmol/mL) in unstimulated whole saliva measured by ELISA.
|
At baseline (single visit)
|
|
Plaque Index
大体时间:At baseline (single visit)
|
Plaque Index (PI) recorded at sampling sites.
|
At baseline (single visit)
|
|
Gingival Index
大体时间:At baseline (single visit)
|
Gingival Index (GI) recorded at sampling sites.
|
At baseline (single visit)
|
|
Probing Depth
大体时间:At baseline (single visit)
|
Probing Depth (PD) recorded at sampling sites.
|
At baseline (single visit)
|
|
Bleeding on Probing
大体时间:At baseline (single visit)
|
Bleeding on Probing (BOP%) recorded at sampling sites.
|
At baseline (single visit)
|
|
Clinical Attachment Level
大体时间:At baseline (single visit)
|
Clinical Attachment Level (CAL) recorded at sampling sites.
|
At baseline (single visit)
|
|
Gingival Crevicular Fluid Volume
大体时间:At baseline (single visit)
|
Gingival crevicular fluid (GCF) volume measured at sampling sites.
|
At baseline (single visit)
|
合作者和调查者
调查人员
- 学习椅:Cüneyt A Aral, Professor, DDS, PhD、Inonu University
出版物和有用的链接
一般刊物
- Papapanou PN, Sanz M, Buduneli N, Dietrich T, Feres M, Fine DH, Flemmig TF, Garcia R, Giannobile WV, Graziani F, Greenwell H, Herrera D, Kao RT, Kebschull M, Kinane DF, Kirkwood KL, Kocher T, Kornman KS, Kumar PS, Loos BG, Machtei E, Meng H, Mombelli A, Needleman I, Offenbacher S, Seymour GJ, Teles R, Tonetti MS. Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Clin Periodontol. 2018 Jun;45 Suppl 20:S162-S170. doi: 10.1111/jcpe.12946.
- Chapple ILC, Mealey BL, Van Dyke TE, Bartold PM, Dommisch H, Eickholz P, Geisinger ML, Genco RJ, Glogauer M, Goldstein M, Griffin TJ, Holmstrup P, Johnson GK, Kapila Y, Lang NP, Meyle J, Murakami S, Plemons J, Romito GA, Shapira L, Tatakis DN, Teughels W, Trombelli L, Walter C, Wimmer G, Xenoudi P, Yoshie H. Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: Consensus report of workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol. 2018 Jun;89 Suppl 1:S74-S84. doi: 10.1002/JPER.17-0719.
- Lim D, Dematteis G, Tapella L, Genazzani AA, Cali T, Brini M, Verkhratsky A. Ca2+ handling at the mitochondria-ER contact sites in neurodegeneration. Cell Calcium. 2021 Sep;98:102453. doi: 10.1016/j.ceca.2021.102453. Epub 2021 Aug 5.
- Lee S, Min KT. The Interface Between ER and Mitochondria: Molecular Compositions and Functions. Mol Cells. 2018 Dec 31;41(12):1000-1007. doi: 10.14348/molcells.2018.0438. Epub 2018 Dec 12.
- Kirmizigul OA, Sabanci A, Disli F, Yildiz S, Milward MR, Aral K. Evaluation of the role of mitofusin-1 and mitofusin-2 in periodontal disease. J Periodontol. 2024 Jan;95(1):64-73. doi: 10.1002/JPER.23-0072. Epub 2023 Jul 24.
- Aral K, Milward MR, Cooper PR. Gene expression profiles of mitochondria-endoplasmic reticulum tethering in human gingival fibroblasts in response to periodontal pathogens. Arch Oral Biol. 2021 Aug;128:105173. doi: 10.1016/j.archoralbio.2021.105173. Epub 2021 May 27.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
关键字
其他相关的 MeSH 术语
其他研究编号
- IUCTEC.2024/06
- TDH-2024-3464 (其他赠款/资助编号:Inönü University Scientific Research Projects Coordination Office)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.